Barlow, J J <br/><br/>
Long-term survival rates with various chemotherapeutic regimens in stages III and IV ovarian adenocarcinoma. The influence of optimum pretreatment surgical resection.  [electronic resource] 

 -  American journal of obstetrics and gynecology  Jun 1985 
 - 310-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0002-9378 
<br/><br/><label>Standard No.: </label>10.1016/s0002-9378(85)80218-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adenocarcinoma, Mucinous--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Child<br/>Cyclophosphamide--administration & dosage<br/>Cystadenocarcinoma--drug therapy<br/>Dactinomycin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Leucovorin--administration & dosage<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Neoplasm Staging<br/>Ovarian Neoplasms--drug therapy<br/>Ovary--surgery<br/>Prognosis<br/>Prospective Studies<br/>Random Allocation<br/>Time Factors